Major pharma companies rejected a 2017 EU proposal that could let vaccines for viruses like the coronavirus be developed before an outbreak

Representatives of a group including GlaxoSmithKline, Pfizer, and Johnson & Johnson are on the body that rejected the proposal, The Guardian reported.